The Stimulants Ecstasy

Total Page:16

File Type:pdf, Size:1020Kb

The Stimulants Ecstasy 7:45 – 9 am Presenter Disclosure Information The following relationships exist related to this presentation: Emerging Drugs of Abuse: From Ecstasy to Bath Salts, Synthetic ►Petros Levounis, MD, MA: No financial relationships to disclose. Cannabinoids, and Beyond Off-Label/Investigational Discussion SPEAKER ►In accordance with pmiCME policy, faculty have been Petros Levounis, MD, MA asked to disclose discussion of unlabeled or unapproved use(s) of drugs or devices during the course of their presentations. Outline Learning Objectives • List the four major classes of emerging drugs of abuse. 1. Stimulants • Identify the pleasurable effects of methylene-dioxy- methamphetamine (MDMA), bath salts, synthetic 2. Cannabinoids cannabinoids, salvia divinorum, dextromethorphan, and kratom. 3. Hallucinogens • Identify major detrimental effects of methylene-dioxy- methamphetamine (MDMA), bath salts, synthetic cannabinoids, salvia divinorum, dextromethorphan, and 4. Opioids kratom. 5. Management • Describe the mechanism of action of street stimulants. 6. Summary 1 Ecstasy The Stimulants Methylene-Dioxy-Meth-Amphetamine (MDMA) Effects • Essentially partly a stimulant and partly a hallucinogen: . An attenuated form of cocaine, plus “Freshmen love it, . An attenuated form of LSD. Sophomores like it, • Empathy (more than ecstasy). Juniors are ambivalent, and • Profound feelings of relatedness to the Seniors are afraid.” rest of the world. • In the 1970s, it was used in psychotherapy (unsuccessfully). Neurobiology Intoxication • Acutely increases serotonin levels by: • “Disco dump” and bruxism. Blocking reuptake, and • Stimulant effects: . Directly releasing the neurotransmitter. Wakefulness, endurance, energy. • Chronically decreases serotonin . Trismus, anorexia, diaphoresis, hot flashes. levels by: • Serotonin Syndrome: . Depleting serotonin stores . Treat with hydration, cooling, and sedation. Inhibiting the synthesis of new serotonin. Do not use beta-blockers, which may • Neurotoxicity. worsen vasospasm and hypertension. Withdrawal Long-term Effects • Anhedonia and depressed mood. • Associated with: • Lethargy and fatigue for several days. Depression . Anxiety • Frank suicidality in the absence of co- . Panic Disorder occurring depressive disorder is rare. Increased impulsivity • No indication for treatment. Sleep disturbances . Cognitive dysfunction • No FDA approved medications. • MET and CBT are the major treatment modalities. Effects • Euphoria Bath Salts • Heightened alertness • Elevated energy • Increased sexual arousal Levounis P and Herron A. The Addiction Casebook. 2014. “Hey, I just met you, 2 and this is crazy, but I’m on bath salts, and your face looks tasty.” The Cannabinoids Names • Spice, Spice Gold, Spice Diamond • K2, K2 Blonde • Aroma • Yucatan Fire Synthetic • XXX • Black Box Cannabinoids • Zombie • Skunk • Moon Rocks • Bizarro Effects • Mild euphoria and relaxation • The giggles “Why drink and drive, • Increased sensitivity to external stimuli: when you can smoke and fly.” . Colors seem brighter . Smells are more pungent “If we all had a bong, • Distortion of time perception we’d all get along.” • Frank, vivid hallucinations Neurobiology SC Neurobiology • Cannabinoids activate the CB1 and CB2 • Synthetic Cannabinoids (SCs) are full and cannabinoid receptors: potent agonist of the CB1 receptor. CB1 has high density in cerebellum, basal ganglia, hippocampus, cerebral cortex. • 4- to 5-fold higher affinity to CB1 receptor. CB has low density in the brainstem, hence low risk 1 • 10-fold higher affinity to CB receptor. of respiratory depression. 2 . CB2 is found in spleen, hematopoietic cell lines, mast • 2 to 3 times more likely to be associated cells. with sympathomimetic effects. CB2 activation may be the primary cause of addiction to cannabis. • Approximately 5 times more likely to be associated with hallucinations. • Anandamide is the endogenous ligand. Forrester MB, Kleinschmidt K, Schwarz E, Young A. Hum Exp Toxicol 2012; 31:1006–11. Synthetic Drug Abuse Prevention Act of 2012 • Cannabimimetic Agents are Schedule I. • “Unless specifically exempted or unless listed 3 in another schedule, any material, compound, mixture, or preparation which contains any quantity of cannabimimetic agents, or which contains their salts, The Hallucinogens isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.” Names • Diviners Sage • Magic Mint • Maria Pastora • Purple Sticky Salvia • Sally D Salvia Divinorum • Salvia Zone Effects • Highly selective kappa opioid receptor agonist Dextromethorphan • Intense hallucinations DXM • Heightened sensations • Synesthesia DXM Effects DXM Plateaus o Great for conversation 1st 100 – 250 mg o Great insights to everything • Low dose – Opioid o “Good for a party or concert!” o More euphoria • Higher dose – Hallucinogen 2nd 250 – 450 mg o Decreased sense of time o Decreased sense of surroundings o Visual hallucinations, mostly spirals and fluids 3rd 450 – 800 mg o Popping up of thoughts and feelings of one's own life o “This is definitely not a party plateau.” o Alien encounters o Out of body experiences th 800 – 1,800 mg 4 o “Not for beginners—not be done without close access to a hospital and a smart trip-sitter.” o Very few reports of a 5th plateau o Profuse sweating, extreme nausea, blackouts th Over 1,800 mg 5 o “Point of no return. Unless you want to go through physical and mental hell, don't try and hit this point.” DXM.darkridge.com The 2C Family 4 e.g., 2,5-dimethoxy-4-iodophenethylamine The Opioids Names • Ithang • Kakuam • Ketum • Krypton Kratom • Thom Mitragyna Speciosa Effects • Low dose – Stimulant • Higher dose – Opioid • 13 times more potent than morphine Krokodil 4,5-α-epoxy-17-methylmorphinan-3-ol Urine Toxicology Examination • “Current immunoassay-based screening methods are not ideal for presumptively 5 identifying most designer drugs.” • In general: Management Opioids give False Negatives, Amphetamines give False Positives, and Cocaine is Cocaine. ForensicMag.com, 2014. Intoxication and Withdrawal Bottom Line • Make a “best guess” about the class of • Opioids: Use Naloxone. the suspected substance based on: • Sedatives: Use Benzodiazepines. Presenting Symptoms • Everything else: Use Supportive Care. History Physical Examination Urine Toxicology Examination • Treat the patient as if she or he had used the prototype of that class. ForensicMag.com, 2014. Addiction Resources • No FDA-approved medications and none recommended. • NIDA.gov (Reliable but less current) • Coordination of care with addiction counselors, clinics, and psychiatrists. • Wikipedia.org JUST PERFECT • Psychosocial Approaches: Erowid.org (Current but less reliable) 12-Step Facilitation • Cognitive Behavioral Therapy Motivational Interviewing GOOD BAD X Empathy Panic Bath Salts Happiness Addiction 6 SC Euphoria Psychosis Salvia Visions Flashbacks Summary DXM Insights Hell Kratom Pain Relief Death Krokodil Not Here Zombie Thank you NJMS.Rutgers.edu/Psychiatry.
Recommended publications
  • 1 Title Page Pharmacological Comparison of Mitragynine and 7
    JPET Fast Forward. Published on December 31, 2020 as DOI: 10.1124/jpet.120.000189 This article has not been copyedited and formatted. The final version may differ from this version. JPET-AR-2020-000189R1: Obeng et al. Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for Mu-Opioid Receptor and Morphine-Like Discriminative-Stimulus Effects in Rats. Title Page Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for Mu-Opioid Receptor and Opioid-Like Behavioral Effects in Rats Samuel Obeng1,2,#, Jenny L. Wilkerson1,#, Francisco León2, Morgan E. Reeves1, Luis F. Restrepo1, Lea R. Gamez-Jimenez1, Avi Patel1, Anna E. Pennington1, Victoria A. Taylor1, Nicholas P. Ho1, Tobias Braun1, John D. Fortner2, Morgan L. Crowley2, Morgan R. Williamson1, Victoria L.C. Pallares1, Marco Mottinelli2, Carolina Lopera-Londoño2, Christopher R. McCurdy2, Lance R. McMahon1, and Takato Hiranita1* Downloaded from Departments of Pharmacodynamics1 and Medicinal Chemistry2, College of Pharmacy, University of Florida jpet.aspetjournals.org #These authors contributed equally Recommended section: Behavioral Pharmacology at ASPET Journals on September 29, 2021 Correspondence: *Takato Hiranita, Ph.D. Department of Pharmacodynamics, College of Pharmacy, University of Florida 1345 Center Drive, Gainesville, FL 32610 Email: [email protected] Phone: +1.352.294.5411 Fax: +1.352.273.7705 Keywords: kratom, mitragynine, 7-hydroxymitragynine, morphine, opioid, discriminative stimulus Conflicts of Interests or Disclaimers: None Manuscript statistics: Number of text pages: 56 Number of tables: 7 Number of figures: 10 Number of supplementary Tables: 4 Number of supplementary figures: 7 1 JPET Fast Forward. Published on December 31, 2020 as DOI: 10.1124/jpet.120.000189 This article has not been copyedited and formatted.
    [Show full text]
  • Disclosures Background on Kratom
    1/23/2019 Pharmacy Technician Learning Objectives • Review the history, mechanism of action, off‐label uses, and common Kratom: An side effects of kratom • Distinguish between state and federal laws for kratom and why this is Herbal relevant to patient’s use Supplement of • Identify possible treatments for kratom overdose Atomic Concern? Taylor Conklin, PharmD PGY1 Pharmacy Resident Northwestern Memorial Hospital January 22, 2019 Advisor: Robert Pecho, PharmD Clinical Pharmacist PGY1 Pharmacy Practice Coordinator Northwestern Memorial Hospital Disclosures Background on Taylor Conklin and Robert Pecho do not have any conflicts of interest to disclose regarding the subject matter Kratom Pharmacist Learning Objectives Kratom in the Media • Review the history, pharmacology, off‐label indications, and side effect profile of kratom • Distinguish current federal and state legislation regarding kratom and question how it relates to current use • Discuss historical strategies for management of kratom intoxication and outline plans to treat patients https://www.youtube.com/watch?v=P9SIjuHaiXA Image from Joe Rogan Experience (Podcast) http://podcasts.joerogan.net/. Accessed December 23, 2018. Mark Hay. “Inside Kratom, the Gas Station Drug That Could End the Opioid Crisis. https://www.vice.com/en_us/article/gyd587/kratom-opioid-crisis. Accessed December 23, 2018. Joe Rogan Podcast https://www.youtube.com/watch?v=P9SIjuHaiXA. Accessed December 23, 2018. 1 1/23/2019 Patient Case #1 Growth to Western Civilization Sally Sassafras PubMed - Articles on
    [Show full text]
  • A New Data Repository for Pharmacokinetic Natural Product-Drug Interactions: From
    Title Page A New Data Repository for Pharmacokinetic Natural Product-Drug Interactions: from Chemical Characterization to Clinical Studies Caroline Birer-Williams, Brandon T. Gufford, Eric Chou, Marijanel Alilio, Sidney VanAlstine, Rachael E. Morley, Jeannine S. McCune, Mary F. Paine, Richard D. Boyce CBW, EC, RDB - Department of Biomedical Informatics, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania, United States MA – School of Pharmacy, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania, United States SVA, RM – School of Pharmacy, University of Utah, Salt Lake City, Utah, United States BTG – Covance Inc., Clinical Pharmacology, Madison, Wisconsin, United States JSM – Department of Population Sciences and Department of Hematology & HCT, City of Hope Comprehensive Cancer Center, Duarte, CA, United States 1 MFP - Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, United States J.S.M., M.F.P., R.D.B. – Center of Excellence for Natural Product Drug Interaction Research 2 Running Title Page: Running Title: The NaPDI Center Data Repository Corresponding author: Richard D. Boyce, PhD Suite 419, 5607 Baum Blvd Pittsburgh, PA 15206 +1 412 648 9219 [email protected] Number of text pages: Number of tables: 2 Number of figures: 5 Number of references: 60 Number of words in the Abstract: 188 Number of words in the Introduction: 564 Number of words in the Discussion: 583 List of nonstandard abbreviations: FAIR: findable, accessible, interoperable and reusable NP: natural product NPDI: NP-drug interaction NaPDI Center: Center of Excellence for Natural Product Drug Interaction Research 3 Abstract There are many gaps in scientific knowledge about the clinical significance of pharmacokinetic natural product-drug interactions (NPDIs) in which the NP is the precipitant and a conventional drug is the object.
    [Show full text]
  • Den Zauberpilze-Trip Bald Auf Rezept?
    FrequentlyAskedQuestions Forschung –––Gibt es sagt Watts.DaPsilocybininGroßbritannien noch in der Kategorie„Schedule One“ geführt wird undsozu denZauberpilze-Trip gefährlichenillegalen Drogen wieKokainund Heroin 2 zählt, gestaltetsichdie Erforschungschwierig.Doch nichtnur Forscher hoffenauf eine Entwicklungwie bald aufRezept? beiCannabis,was in immermehrLändernals Medizi- nalhanfvon bestimmten Patienten konsumiert werden darf –wie etwa in Deutschlandund England,was vor wenigenJahrennochundenkbar schien.Inden Verei- Text nigten Staaten istCannabisbereitsBig Business,und anne philippi Seitdemman weiß, dass sich Apple-Mitgründer Steve der Marktfür psychedelische Pilze wird in Kalifornien, Jobs einstauchvon LSDinspirieren ließ unddassdas dasimmer schoneineVorreiterrollehatte,als dernächste SiliconValleydie sogenannten „Nootropics“,also„smart großePost-Cannabis-Markt angesehen. Investoren vor drugs“, zurVerbesserung vonKreativität wiederentdeckt allemaus der Bio-Techwelt stehen bereit, entsprechende hat, kehrtauchdas Interessen an LSDund Psilocybin Studienzufinanzieren. Solche,die zu einerschnelle- zurück,das in psychoaktivenPilzenenthalten ist, die renLegalisierung der Stoffeineinem therapeutischen auchals Zauberpilze, MagicMushrooms oder halluzino- Rahmen beitragenkönnten.SohabenGroßinvestor gene Pilze bekannt sind.Zunehmend aber werden diese Peter Thiel undChristian Angermayer Geld in das Substanzenauchals Heilmittel gegenDepressionund Start-up CompassPathwaysgesteckt, welchesPsilocybin Angstzuständeerforscht.Kürzlichersthat dasImperial
    [Show full text]
  • Biochemical Benefits, Diagnosis, and Clinical Risks Evaluation of Kratom
    REVIEW published: 24 April 2017 doi: 10.3389/fpsyt.2017.00062 Biochemical Benefits, Diagnosis, and Clinical Risks Evaluation of Kratom Dimy Fluyau1* and Neelambika Revadigar2 1 Brain Health, Emory University, Atlanta, GA, USA, 2 Columbia University, New York, NY, USA Background: Kratom (Mitragyna speciosa) is a tropical tree with a long history of tradi- tional use in parts of Africa and Southeast Asia. Kratom is also known as Thom, Thang, and Biak. Its leaves and the teas brewed from them have long been used by people in that region to manage pain and opioid withdrawal and to stave off fatigue. Kratom is actually consumed throughout the world for its stimulant effects and as an opioid substi- tute (in form of tea, chewed, smoked, or ingested in capsules). Some case reports have associated kratom exposure with psychosis, seizures, intrahepatic cholestasis, other medical conditions, and deaths. The clinical manifestations of kratom effects are not well defined and the clinical studies are limited. Data research suggest that both stimulant and sedative dose-dependent effects do exist, in addition to antinociceptive, antide- pressant activity, anxiolytic-like effects, and anorectic effects, but a growing concern for the drug’s effects and safety of use has resulted in national and international attention primarily due to an increase in hospital visits and deaths in several countries that are Edited by: believed to have been caused by extracts of the plant. There is a dearth of double blind Angelo G. I. Maremmani, controlled studies. In this study, we aim to use existing literature to clarify both benefits North-Western Tuscany Region, Italy and risks of kratom as well as its diagnosis evaluation as kratom misuse is an emerging Reviewed by: trend in the Western world.
    [Show full text]
  • Brain Magnetic Resonance Imaging of Regular Kratom (Mitragyna Speciosa Korth.) Users: a Preliminary Study
    Malaysian Journal of Medicine and Health Sciences (eISSN 2636-9346) ORIGINAL ARTICLE Brain Magnetic Resonance Imaging of Regular Kratom (Mitragyna speciosa Korth.) Users: A Preliminary Study Darshan Singh1, Yann Chye2, Chao Suo2, Murat Yücel2, Oliver Grundmann3, Muhamad Zabidi Ahmad4, Eric Tatt Wei Ho5, Sharif Mahsufi Mansor1, Siti Rafidah Yusof1, Christopher R. McCurdy3, Christian Mϋller6, Edward W. Boyer7, Balasingam Vicknasingam1 1 Centre for Drug Research, Universiti Sains Malaysia. 11800 Minden, Penang. Malaysia. 2 Brain & Mental Health Research Hub, Monash Institute of Cognitive and Clinical Neuroscience, School of Psychological Sciences, Monash University. 3 Department of Medicinal Chemistry, College of Pharmacy, University of Florida, 1345 Center Drive, Gainesville, FL 32610, USA. 4 Oncological and Radiological Sciences Cluster, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Bertam, 13200 Kepala Batas, Pulau Pinang, Malaysia 5 Center for Intelligent Signal & Imaging Research, Universiti Teknologi PETRONAS, Perak, Malaysia. 6 Department of Psychiatry and Psychotherapy, University Clinic, Friedrich-Alexander-University Erlangen-Nuremberg, Schwabachanlage 6, 91054 Erlangen, Germany. 7 Department of Emergency Medicine, Brigham and Women’s Hospital, Harvard Medical School, 25 Shattuck St, Boston, MA 02115, USA. ABSTRACT Introduction: Mitragyna speciosa (Korth.) or kratom is a native medicinal plant of Southeast Asia. Commonly used by hard labours in harsh working environment, the ingestion of brewed kratom decoction is reported to produce dose-dependent stimulant and opioid-like effects. Kratom is also regularly consumed as a pain killer and as tradi- tional cure for common maladies such as fever and cough. However, it remains unknown whether regular consump- tion of kratom decoction is associated with brain abnormalities in regular users in traditional settings.
    [Show full text]
  • (Mitragyna Speciosa) Use Among Ketum Leaf Users in Malysia
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Repository@USM MEASURING DEPENDENCE SEVERITY OF KETUM (MITRAGYNA SPECIOSA) USE AMONG KETUM LEAF USERS IN MALYSIA by DARSHAN SINGH A/L MAHINDER SINGH Thesis submitted in fulfilment of the requirements for the degree of Doctor of Philosophy April 2013 ACKNOWLEDGEMENT I would like to express my appreciation and gratitude to my principal supervisor Associate Professor Dr.B.Vicknasingam Kasinather, for all his indispensible support and valuable guidance during my study at the Centre for Drug Research, Universiti Sains Malaysia. I am also grateful to my co-supervisor the Director of Centre for Drug Research Professor Sharif Mahsufi Mansor, for all his excellent guidance and moral support. I would also thank Mr. Firdaus Bin Ramli from the Centre for Drug Research, for dedicating his precious time in helping me with my data collection. My special thanks to Miss Vemala Devi from the Centre for Drug Research, who obsequiously helped to edit my thesis. I also extent my sincere appreciation to Professor Suresh Narayanan from the School of Social Sciences, for guiding me in my statistical analysis work. I would also like to thank the Ministry of Sains and Technology (MOSTI) for financially supporting my research work. Last but not least, I thank Almighty for blessing me to excel in my studies. Finally I want to also thank both my loving parents the Late Mr. Mahinder Singh and Madam Jagjit Kaur who always encouraged me to do well in all my endeavours. ii TABLES OF CONTENTS Acknowledgement..........................................................................................
    [Show full text]
  • Novel Case of Maternal and Neonatal Kratom Dependence and Withdrawal
    CASE REPORTÉDITORIAL Novel case of maternal Editor’s key points Kratom is a legally obtainable and and neonatal kratom easily accessible drug with harmful effects, addiction potential, and dependence and withdrawal withdrawal symptoms comparable to what is seen with common opioids. Lindsay Mackay MD CCFP Ronald Abrahams MSc MD CCFP FCFP Kratom withdrawal in neonates he opioid crisis is growing across Canada, resulting in devastating mor- should be treated with rooming-in and close contact with the mother bidity and mortality.1 It is vital that awareness be raised within the as the standard of care to prevent medical community concerning kratom, a legally obtainable and easily neonatal intensive care unit Taccessible drug with harmful effects and addiction potential comparable to admission and to prevent or reduce what is seen with common opioids. morphine use. Case Clinicians should ask patients about their use of legal herbal supplements, A 29-year-old woman with 4 pregnancies, 1 birth of viable offspring, and 3 specifically kratom, and educate abortions was admitted on postpartum day 2 from another hospital with the patients about their risks. goal of tapering her daily kratom use. Her infant was transferred to a tertia- ry neonatal intensive care unit (NICU) to be treated for neonatal withdrawal. The patient was admitted to an inpatient combined care unit for pregnant Points de repère and postpartum women who struggle with addiction. du rédacteur The patient was in a stable relationship with the baby’s father and came Le kratom est une substance from a supportive family. She was employed full-time and her housing was médicinale légalement et facilement considered adequate.
    [Show full text]
  • CBD Oil and Other Drugs
    Drugs of Concern JOHNNY ROGERS MANAGER ACCESS SERVICES/FFD TENNESSEE VALLEY AUTHORITY Marijuana, A Drug of Choice . According to NBC news, there has been an increase by up to 6 percent in the number of highway crashes in four of the states where the recreational use of marijuana has been legalized, according to a pair of new studies. Potency rates continue to climb, modern weed usually contains THC levels of 18 to 30% — more than double the levels that were common in buds from the 1980s. (Arizona Public News) . Today’s marijuana has as much similarity to the pot brownies of the 1970s as a smart phone does to a Texas Instruments calculator. Today’s marijuana is incredibly potent, powerful enough to destroy lives. (Arizona Pubic News) ©2019 Nuclear Energy Institute 2 Marijuana, California Highway Patrol officers investigate a multicar accident, several killed ©2019 Nuclear Energy Institute 3 NBC News Reports • The report data does not prove there’s a direct risk caused by the use of marijuana among motorists, but it raises caution flags • No easy way to test drivers to be sure if they are, in fact, under the influence of THC • Trend is moving in the wrong direction • Since the legalization wave began, safety and health experts have been trying to measure the potential influence on highway safety. • Results so far have been inconsistent and, in some cases, contradictory, this is the second year in a row where the IIHS found this troubling trend. ©2019 Nuclear Energy Institute 4 Traffic fatalities linked to marijuana are up sharply in Colorado.
    [Show full text]
  • A Simple and Cost Effective Isolation and Purification Protocol of Mitragynine from Mitragyna Speciosa Korth (Ketum) Leaves
    The Malaysian Journal of Analytical Sciences, Vol 15 No 1 (2011): 54 - 60 A SIMPLE AND COST EFFECTIVE ISOLATION AND PURIFICATION PROTOCOL OF MITRAGYNINE FROM MITRAGYNA SPECIOSA KORTH (KETUM) LEAVES (Satu Protokol Pengasingan Mitragina daripada Daun Mitragyna speciosa Korth (Ketum) yang Mudah dan Kos Efektif) Goh Teik Beng1* , Mohamad Razak Hamdan1, Mohammad Jamshed Siddiqui2, Mohd Nizam Mordi1 and Sharif Mahsufi Mansor1 1Centre of Drug Research, 2 School of Pharmaceutical Science, Universiti Sains Malaysia, Minden 11800, Penang, Malaysia. *Corresponding author: [email protected] Abstract The objective of the present study was to develop a simple and cost effective method for the isolation of mitragynine from Mitragyna speciosa Korth leaves. The results of our study showed that around 0.088 % (w/w) pure mitragynine was obtained by this newly developed method with a purity of 99.0 % (w/w) based on GC-MS analysis. Moreover, the recovery of the pure mitragynine from the chloroform extract was also more than 95.0 %. Advantages of this new method were simpler, faster and more economical. In conclusion this simple and cost effective method helps to isolate mitragynine with higher purity in comparison with the published methods. Keywords: Mitragynine speciosa Korth, mitragynine, mitragynine extraction Abstrak Objektif kajian ini adalah untuk membangunkan satu kaedah yang mudah dan kos efektif untuk pengasingan mitraginina daripada daun Mitragyna speciosa Korth. Keputusan kajian menunjukkan bahawa lebih kurang 0.088 % (w/w) mitraginina tulen telah diperolehi dengan menggunakan kaedah baru yang dibangunkan ini dengan ketulenan 99.0 % (w/w) berdasarkan analysis GC-MS. Malahan, hasil pemerolehan semula mitraginina tulen daripada ekstrak kloroform juga melebihi 95.0 %.
    [Show full text]
  • Patterns of Recreational Drug Use and Harm Reduction Strategies Among Women at Music Festivals: the Case of Hungary and Poland Iga Kender-Jeziorska
    Chapter 23 Patterns of Recreational Drug Use and Harm Reduction Strategies among Women at Music Festivals: The Case of Hungary and Poland Iga Kender-Jeziorska Introduction The prevalence of use of club drugs among young adults in Europe has been stable for the last decade. For example, last year’s use of cocaine and amphet- amine in the general population of 15–34 years olds decreased by 0.1% each, while 3,4-methylenedioxymethamphetamine (MDMA) use has increased by 0.1% (European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2009, 2019). It is argued that recreational use of psychoactive substances has been undergoing a process of normalisation, gaining increasing societal acceptance (Parker, Williams, & Aldridge, 2002). Although certain aspects of this theory have been criticised (e.g. Gourley, 2004; Williams, 2016), the evidence seems to support the normalisation thesis in two major contexts: among youth (Cheung & Cheung, 2006; van der Poel, Rodenburg, Dijkstra, Stoele, & van de Mheen, 2009; Wilson, Bryant, Holt, & Treloar, 2010) and in party–club settings (Duff, 2005; Hutton, 2010; Ravn, 2012). In support of the normalisation theory in party settings, the research shows show that the prevalence of illicit drug use among people participating in the nightlife economy is much higher than in the general population (EMCDDA, 2006). In Oslo, 25% of young adults surveyed have reported last month drug use (Nordfjærn, Bretteville-Jensen, Edland-Gryt, & Gripenberg, 2016, p. 3); in Edin- burgh, 35% of study participants have declared using ecstasy every week (Riley, James, Gregory, Dingle, & Cadger, 2001, p. 1035); in Rome, 39% of club-goers The Impact of Global Drug Policy on Women: Shifting the Needle, 201–211 Copyright © 2021 by Iga Kender-Jeziorska These works are published under the Creative Commons Attribution (CC BY 4.0) licence.
    [Show full text]
  • KRATOM COMBOS and Probably Pretty Poorly with Ayahuasca (Which Has a More Sedative Effect)
    VOLUME XIII, NUMBER 2 SUMMER SOLSTICE 2004 This isolation approach consists of adding 100 ml of a solu- other entheogens. I discovered that kratom is very effective tion containing 20% potassium iodine and 10% iodine per when used with tobacco. Kratom is also great in combina- 10 liters of alkaloid-base bearing solution, while stirring. The tion with a kava kava (Piper methysticum) extract. My favor- precipitate is then collected by filtration. The alkaloid is re- ite combination is kratom, kava, and Cannabis. This produces generated by dissolving in one liter of chloroform and shak- the most narcotic and euphoric ten hours I have ever experi- ing with 500 ml of a solution of 5% sodium hydroxide and enced. Strangely, kratom and Cannabis together (without the 10% sodium thiosulfate. The chloroform is then separated, kava) takes me "nowhere" and seems to be a useless combi- dried over anhydrous sodium sulfate and the solvent re- nation. I also found the combination of kratom and opium moved under reduced pressure. Efficiency for the use of this to be rather uninteresting. It appears as though the worst process to recover lysergic acid amide as a crystallizing resi- combinations with kratom are those that add an additional due was reported to be 65% from a fermentation broth con- depressant quality without also adding some sort of stimu- taining 1.5 micrograms per ml. lant into the mix. This was reported to reduce the volume of solvents used in I did several experiments mixing kratom with Psilocybe the process, and therefore the overall volume ofliquids re- cubensis.
    [Show full text]